Preexisting memory CD4+ T cells contribute to the primary response in an HIV-1 vaccine trial.
Campion SL, Brenna E, Thomson E, Fischer W, Ladell K, McLaren JE, Price DA, Frahm N, McElrath JM, Cohen KW, Maenza JR, Walsh SR, Baden LR, Haynes BF, Korber B, Borrow P, McMichael AJ.
Campion SL, et al.
J Clin Invest. 2021 Dec 1;131(23):e150823. doi: 10.1172/JCI150823.
J Clin Invest. 2021.
PMID: 34850742
Free PMC article.
Clinical Trial.